P N A Harris
Overview
Explore the profile of P N A Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart A, Price E, Schabacker K, Birikmen M, Harris P, Choong K, et al.
Antimicrob Agents Chemother
. 2021 Mar;
65(6).
PMID: 33781999
Third-generation cephalosporin-resistant (3GC-R) represent a major threat to human health. Here, we captured 288 3GC-R clinical isolates from 264 patients presenting at a regional Australian hospital over a 14-month period....
2.
Henderson A, Paterson D, Chatfield M, Tambyah P, Lye D, De P, et al.
Clin Infect Dis
. 2020 Oct;
73(11):e3842-e3850.
PMID: 33106863
Introduction: This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial. Methods: Blood culture isolates...
3.
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect
. 2020 Jan;
26(6):801.
PMID: 31968270
No abstract available.
4.
McNamara J, Harris P, Chatfield M, Lorenc P, Paterson D
Clin Microbiol Infect
. 2019 Oct;
26(2):257.e1-257.e4.
PMID: 31654791
Objectives: To evaluate the sequential organ failure assessment (SOFA) and modified SOFA (mSOFA) scoring and a novel performance score based on the Karnofsky score for measuring outcome following a bloodstream...
5.
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect
. 2019 Jul;
26(1):35-40.
PMID: 31306790
Background: Most intensive care unit (ICU) patients receive broad-spectrum antibiotics. While lifesaving in some, in others these treatments may be unnecessary and place patients at risk of antibiotic-associated harms. Objectives:...
6.
Harris P, McNamara J, Lye D, Davis J, Bernard L, Cheng A, et al.
Clin Microbiol Infect
. 2016 Nov;
23(8):533-541.
PMID: 27810466
Objectives: To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI). Methods: Prospective studies, randomized trials or registered protocols comparing antibiotic therapies...
7.
Harris P, Alder L, Paterson D
Pathology
. 2015 May;
47(4):386-8.
PMID: 25938360
No abstract available.
8.
Harris P, Ferguson J
Int J Antimicrob Agents
. 2012 Jul;
40(4):297-305.
PMID: 22824371
Some bacteria that possess chromosomally determined AmpC β-lactamases may express these enzymes at a high level following exposure to β-lactams, either by induction or selection for derepressed mutants. This may...